MedTrace Logo

PerAF: AF Termination vs Prespecified Ablation

NCT06837441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 195

Last updated 2025-02-20

No results posted yet for this study

Summary

The design of this study is an intervention, randomized, controlled study and contains two randomized groups：（1）AF-termination group；（2）Prespecified-ablation group.

Conditions

  • Persistent Atrial Fibrillation

Interventions

PROCEDURE

Atrial Fibrillation Termination

Pursuing Atrial Fibrillation Termination as a Procedural Endpoint

PROCEDURE

Prespecified Ablation

Prespecified Ablation Strategy Followed by Cardioversion

Sponsors & Collaborators

  • The Shanghai Yangpu Central Hospital

    collaborator UNKNOWN

  • Jinshan Hospital Affiliated to Fudan University

    collaborator UNKNOWN

  • Shanghai Chest Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-06-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06837441 on ClinicalTrials.gov